this summary covers the well-studied copper tripeptide GHK-Cu (glycyl-L-histidyl-L-lysineCu)
The scale of it is a growing concern, with projections suggesting that by 2026 , a staggering 1 in 4 Britons could be living with an undiagnosed deficiency
By inhibiting the hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell, it prevents the release of gastric acid
Epithalons Disease-fighting, Anti-cancer, and Antioxidant Effects There is strong research interest in epithalons disease-fighting, anti-cancer, and antioxidant effects, namely in its ability to decrease experimental cancerogenesis and increase longevity in animals [3]
KLOW is not an FDA-approved treatment
BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of a naturally occurring protein compound